Zobrazeno 1 - 10
of 51
pro vyhledávání: '"E. R. Nemtsova"'
Autor:
A. V. Kolesnikov, E. R. Nemtsova, M. M. Shishkin, A. V. Shchul’kin, O. I. Barenina, I. V. Kirsanova
Publikováno v:
Oftalʹmologiâ, Vol 20, Iss 1, Pp 128-135 (2023)
Research justification. Corneal ulcer is a common corneal pathology dangerous because of its complications, which occur in 2.5–37.9 % of cases despite modern treatment. Thus, the development of novel methods improving the results of corneal ulcer t
Externí odkaz:
https://doaj.org/article/0b288e07fac84eccadc215308d18d8b4
Autor:
O, A. Bezborodova, A. A. Pankratov, E. R. Nemtsova, Yu. B. Venediktova, M. S. Vorontsova, G. N. Engalycheva, R. D. Syubaev
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 10, Iss 2, Pp 96-110 (2020)
The decoding of the DNA structure and development of new molecular methods of its analysis, as well as identification of specific genomic changes responsible for malignant transformation, have become the turning points in elaboration of novel anti-tu
Externí odkaz:
https://doaj.org/article/8fa6c6b63dc0459290183b5be3e52dd4
Autor:
N. E. Grammatikova, S. P. Rezvan, E. R. Nemtsova, O. A. Bezborodova, I. L. Tutykhina, B. S. Naroditsky, R. I. Yakubovsky
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 7-8 (2020)
Comparative antimicrobial activity of lactoferrins from various sources (native lactoferrin from Laprot, human hololactoferrin, recombinant human lactoferrin isolated from the cultural medium of permissive cell culture transfected using pseudoadenovi
Externí odkaz:
https://doaj.org/article/fe3487d7de5e4fef9645a5affabe2e21
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 3, Iss 4, Pp 33-43 (2016)
This is a review of modern literature data of official medications for anti-tumor gene therapy as well as of medications that finished clinical trials.The article discusses the concept of gene therapy, the statistical analysis results of initiated cl
Externí odkaz:
https://doaj.org/article/2cbc2d2d6ef04a67a670ead7e0501746
Autor:
A. D. Plyutinskaya, E. R. Nemtsova, A. A. Pankratov, P. V. Shegai, S. S. Krylov, V. N. Iskandarova, A. S. Maksimenko, D. V. Demchuk, T. S. Kuptsova, M. N. Semenova, V. V. Semenov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 174:221-225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c482d5ce2a2ef03273a4a47403688613
https://doi.org/10.1007/s10517-023-05677-6
https://doi.org/10.1007/s10517-023-05677-6
Autor:
E. R. Nemtsova, A. A. Pankratov, N. B. Morozova, V. K. Tischenko, V. M. Petriev, V. V. Krylov, P. V. Shegay, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Biology Bulletin. 49:2285-2297
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bf63d7e9f67ca39dcc424d0b184befe
https://doi.org/10.1134/s1062359022120160
https://doi.org/10.1134/s1062359022120160
Autor:
G. M. Proshkina, S. M. Deev, P V Shegai, Konstantin Kokov, A D Kaprin, B V Egorova, Anna D. Plyutinskaya, A. A. Pankratov, V. A. Golovachenko, M S Vorontsova, E N Lebedenko, E. R. Nemtsova, D. Yu. Chuvilin, A. A. Shulga
Publikováno v:
Bulletin of Experimental Biology and Medicine. 171:627-632
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides 177Lu (ZHER2-HSA-chelator-177Lu) or 212Pb (ZHER2-HSA-chelator-212Pb). The objective was to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b956afdc2d0b483ff906be90f549d47
https://doi.org/10.1007/s10517-021-05283-4
https://doi.org/10.1007/s10517-021-05283-4
Autor:
A. V. Boyko, L. V. Demidova, T. A. Teleus, E. A. Dunaeva, R. I. Yakubovskaya, E. R. Nemtsova, T. V. Sergeeva
Publikováno v:
Kazan medical journal. 81:287-289
The experience of the treatment of cervical cancer with the use of the dynamic fractioning scheme is given. The higher five-year survival rate in the third disease stage compared with the classical functioning regime is noted. The original chemicorad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e4b5c709053290dcc1df8b43808cedc
https://doi.org/10.17816/kazmj99852
https://doi.org/10.17816/kazmj99852
Autor:
A A, Pankratov, E R, Nemtsova, A D, Plyutinskaya, M S, Vorontsova, D Yu, Chuvilin, B V, Egorova, K V, Kokov, S M, Deev, E N, Lebedenko, G M, Proshkina, A A, Shul'ga, V A, Golovachenko, P V, Shegai, A D, Kaprin
Publikováno v:
Bulletin of experimental biology and medicine. 171(5)
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1b2cbe647842056ca49b878260f30f8
https://pubmed.ncbi.nlm.nih.gov/34626281
https://pubmed.ncbi.nlm.nih.gov/34626281
Autor:
J A Tereshkina, E. G. Tikhonova, J. B. Venediktova, A. A. Pankratov, E I Korotkevich, E R Nemtsova, O. A. Bezborodova, L V Kostryukova
Publikováno v:
Bulletin of experimental biology and medicine. 169(6)
Preclinical study of therapeutic properties of an innovative drug Doxorubicin-NPh (doxorubicin in the form of ultrafine suspension of phospholipid liposomes) in comparison with free doxorubicin (Doxorubicin-Teva) and protected doxorubicin (Caelyx) wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59078b685138b345899efcecf031bea6
https://pubmed.ncbi.nlm.nih.gov/33123920
https://pubmed.ncbi.nlm.nih.gov/33123920